Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma

BACKGROUND: Fluticasone furoate/vilanterol (FF/V) is an effective long-acting β2 agonist/inhaled corticosteroid combination for managing persistent bronchial asthma. The aim of the study was to assess the outcomes achievable in patients with mild to moderate asthma receiving FF/V 92/22 µg once daily...

Descripción completa

Detalles Bibliográficos
Autores principales: Dal Negro, Roberto W., Bonadiman, Luca, Turco, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144589/
https://www.ncbi.nlm.nih.gov/pubmed/30215289
http://dx.doi.org/10.1177/1753466618789894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144589/
https://www.ncbi.nlm.nih.gov/pubmed/30215289
http://dx.doi.org/10.1177/1753466618789894

Ejemplares similares